Poly(amidoamine)-Cholesterol Conjugate Nanoparticles Obtained by Electrospraying as Novel Tamoxifen Delivery System
Author(s) -
Roberta Cavalli,
Agnese Bisazza,
R. Bussano,
Michele Trotta,
Andrea Civra,
David Lembo,
Elisabetta Ranucci,
Paolo Ferruti
Publication year - 2011
Publication title -
journal of drug delivery
Language(s) - English
Resource type - Journals
eISSN - 2090-3014
pISSN - 2090-3022
DOI - 10.1155/2011/587604
Subject(s) - tamoxifen , conjugate , nanoparticle , amidoamine , materials science , cytotoxicity , drug delivery , chemistry , chemical engineering , nanotechnology , polymer chemistry , dendrimer , biochemistry , mathematics , medicine , mathematical analysis , cancer , breast cancer , engineering , in vitro
A new poly(amidoamine)-cholesterol (PAA-cholesterol) conjugate was synthesized, characterized and used to produce nanoparticles by the electrospraying technique. The electrospraying is a method of liquid atomization that consists in the dispersion of a solution into small charged droplets by an electric field. Tuning the electrospraying process parameters spherical PAA-chol nanoparticles formed. The PAA-cholesterol nanoparticles showed sizes lower than 500 nm and spherical shape. The drug incorporation capacity was investigated using tamoxifen, a lipophilic anticancer drug, as model drug. The incorporation of the tamoxifen did not affect the shape and sizes of nanoparticles showing a drug loading of 40%. Tamoxifen-loaded nanoparticles exhibited a higher dose-dependent cytotoxicity than free tamoxifen, while blank nanoparticles did not show any cytotoxic effect at the same concentrations. The electrospray technique might be proposed to produce tamoxifen-loaded PAA-chol nanoparticle in powder form without any excipient in a single step.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom